CDK4 and acute myeloid leukemia: 2.1.3. AML with High ABCB1 and Low ORAI1 Gene Expression Shows Reduced Expression of CD33 (Differentiation Marker) and CDK4/CDK6 (G0–G1 Transition Phase Regulators)